← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2020Last known activity
Dec 26, 2024
Timeline
2020s
- Jun 1, 2020
UTC Therapeutics Inc.— Founded
Drugs by trial phase (12 distinct, 17 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (20)
- NCT06937567CollaboratorEarly Phase 1Dec 26, 2024
- NCT06658951Lead sponsorN/ANov 30, 2024
- NCT06641453OfficialPhase 1/Phase 2Nov 15, 2024
- NCT07010523CollaboratorN/AOct 15, 2024
- NCT06501183CollaboratorPhase 1Jul 8, 2024
- NCT06256055Lead sponsorPhase 1Mar 5, 2024
- NCT05990621CollaboratorPhase 1Jul 31, 2023
- NCT05948033Study directorPhase 1/Phase 2Jul 15, 2023
- NCT05947487CollaboratorPhase 1/Phase 2Jul 15, 2023
- NCT05947487Study directorPhase 1/Phase 2Jul 15, 2023
- NCT05948033CollaboratorPhase 1/Phase 2Jul 15, 2023
- NCT05783089CollaboratorPhase 1Apr 30, 2023
- NCT05848999CollaboratorPhase 1Apr 27, 2023
- NCT05775666CollaboratorPhase 1Mar 31, 2023
- NCT05693844Study directorPhase 1/Phase 2Jan 20, 2023
Details
- Founded
- Shanghai, CN Jun 1, 2020
- Last known activity
- Dec 26, 2024